成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Lianhe Aigen Pharmatech Co.,Ltd.

Lianhe Aigen Pharmatech Co.,Ltd.

Main products: Intermediatess,Building blocks,APIs,CRO (FTE/FFS),CDMO

Current Location: HOME >> Enterprise Certification

Contact information

Lianhe Aigen Pharmatech Co.,Ltd.
Country: China
Tel: +86-18918657159
Mobile: +undefined18918657159
E-mail: sales-Aigen@lianhetech.com
QQ:
Skype: Chat Now!
Address: Building 5,No. 199, East GuangFulin Road, Songjiang District, Shanghai,China

Gold product

Company Profile

Lianhe Aigen Pharmatech Co., Ltd., a wholly-owned subsidiary of Lianhe Aigen Pharma Co., Ltd. (formerly known as Lianhe Chemical Technology (Taizhou) Co., Ltd.), is committed to providing one-stop CRDMO services including new drug discovery, preclinical, clinical and commercial stages for the world's leading innovative pharmaceutical companies, empowering global innovative drugs and contributing to human health.

Enterprise Basic Information

Enterprise Certification

Enterprise Certification

Business License Of EnterpriseLegal Person
Type of Enterprise: Limited liability company
Legal Representative: Jianzhong Zhang
Registered Capital: 50000000RMB
Founded Date: 2021-08-20
Registered Address: 5/F, Building 5,No. 199, East GuangFulin Road, Songjiang District, Shanghai
Term of Validity: Long-term
Business Scope: Licensed project: Inspection and testing services. (For projects that require approval according to law, business activities can only be carried out with the approval of relevant departments. The specific business projects shall be subject to the approval documents or licenses of relevant departments.) General projects: technical services, technical development, technical consultation, technical exchange, technology transfer, and technology promotion; Sales of chemical products (excluding licensed chemical products); Sales of specialized chemical products (excluding hazardous chemicals); Sales of mechanical equipment; Sales of instruments and meters; Import and export of goods; Technology import and export. (Except for projects that require approval in accordance with the law, business activities shall be carried out independently with the business license in accordance with the law)
Staff number: Above 500 People
Number of R & D department: Above 100
Annual turnover: RMB Above 100 million
Main consumer market: Pharmaceutical factory  Biotech company  Fine chemical plant 
Main marketing location: China 
Main product or service: APIs, Intermediates, Building blocks

Manufacturer

Marketing : Lianhe Aigen Pharmatech Co.,Ltd.
Address: Building 5,No. 199, East GuangFulin Road, Songjiang District, Shanghai,China
Area: 4000+m2
Pictures of scenes:
  • Pictures of scenes
  • Pictures of scenes
  • Pictures of scenes
Marketing : Lianhe Aigen Pharma Co., Ltd. (formerly Lianhe Che
Address: No.3 Donghai 8th Avenue, Toumengang New District, Linhai, Taizhou City, Zhejiang Province, China
Area: 305,333m2
Equipment: Pharma Site
Pictures of scenes:
  • Pictures of scenes
    Pharma Site
  • Pictures of scenes
    Pharma Site
  • Pictures of scenes
    Pharma Site
  • Pictures of scenes
    Pharma Site
Brief description : Our facilities are successfully inspected and approved by FDA, EMA, PMDA, TGA, KFDA and NMPA
Quality inspection equipment: UPLC, HPLC, ?GC, IC,LC-CAD;LC-MS, LC-MS/MS, GC-MS/
  • equipment
    UPLC
  • equipment
    UPLC
Certificate of accreditation: ISO9001/14001/45001
  • Certificate of accreditation
    ISO9001/14001/45001
Brief description : 17 Workshops:9 cGMP+7 Non-GMP; Production Capacity: about 2500 m3 volume;
Pictures of scenes:
  • Pictures of scenes
  • Pictures of scenes
  • Pictures of scenes
  • Pictures of scenes
Staff composition for example: Employees:1500+ Scientist: 200+
Professional skills: Drug Discovery ? Scaffold design for hit identification ? Library synthesis ? Generation and optimization of hit compounds ? Identification and optimization of lead compounds ? Scaling-up synthesis and process optimization of preclinical candidate compounds ? Patent filing support Process Development ? Process development and optimization of innovative APIs & intermediates of pre-clinical/clinical/commercial stage ? Analytical method development and optimization of Innovative APIs & Intermediat
Pictures of scenes:
  • SHEQ&C First